SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

• 作者Nuijten, M; Mickisch, G
• 卷第102卷
• 期第1期
• 印刷ISSN0007-0920
• 电子ISSN1532-1827
• 文件大小107.65KB
• 发表时间2010
• DOI10.1038/sj.bjc.6605446
• 页码232-233